Compositions and methods for adoptive cell therapy for cancer
US12241097B2 · kind B2 · utility
0Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2018 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Jul 13, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compositions and methods for adoptive cell therapy comprising engineered immune cells that express a tumor antigen-targeted chimeric antigen receptor and a prodrug converting enzyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.